Records containing: Hepatocellular Carcinoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2023-08-15
A Single-arm Exploratory Clinical Study of Conversion Treatment of Hepatic Arterial Infusion Chemotherapy Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2023-08-15
Hepatic Arterial Infusion Chemotherapy Plus Toripalimab Versus Hepatic Arterial Infusion Chemotherapy Plus Sorafenib for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: a Non-comparative, Prospective, Randomized Trial
CLINICAL_TRIALS study record update · 2023-08-14
Role of Dynamic Contrast-Enhanced Ultrasound (D-CEUS) and Shear-wave Elastography (SWE) in Predicting Response to Locoregional Treatments and Disease Recurrence in Patients Affected by Hepatocellular Carcinoma (HCC)
CLINICAL_TRIALS study record update · 2023-08-08
RadioEmbolizaTion Using hOlmium-166 in Patients With Unresectable Hepatocellular Carcinoma: Prospective, Open Label, Single-center Pilot Study
CLINICAL_TRIALS study record update · 2023-08-04
A Phase II/III, Randomized, Open-label, Multi-center Study to Evaluate the Efficacy and Safety of QL1706 in Combination With Bevacizumab and/or Chemotherapy Versus Sintilimab in Combination With Bevacizumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2023-08-03
The Impacts of preopeRative sErum Albumin Levels on Postoperative Outcomes in Chinese HCC Patients Treated With Surgical Operation: REAL Study
CLINICAL_TRIALS study record update · 2023-08-02
Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2023-08-02
Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2023-08-02
Comparison of Hepatitis B Virus Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing Immune Checkpoint Inhibitor and Concurrent Antiviral Prophylaxis: a Prospective Observational Study
CLINICAL_TRIALS study record update · 2023-08-01
Predictors of Sorafenib Response in Patients With Advanced Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2023-08-01
A Prospective Clinical Study of Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2023-07-28
Pharmacogenetic Study in Hepatocellular Carcinoma Patients Underwent TACE
CLINICAL_TRIALS study record update · 2023-07-20
Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma: a Phase II, Single-arm, Prospective Study
CLINICAL_TRIALS study record update · 2023-07-14
Efficacy and Safety of Transarterial Chemoembolization in Combination With Immune Checkpoint Inhibitors for Hepatocellular Carcinoma: a Real-world Study
CLINICAL_TRIALS study record update · 2023-07-13
A Phase 1b/2 Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2023-07-13
Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation: a Single-arm Exploratory Study
CLINICAL_TRIALS study record update · 2023-07-12
A Phase 1b/2, Open-Label, Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2023-07-11
Phase II Study of Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in Patients With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
CLINICAL_TRIALS study record update · 2023-07-11
Feasibility of 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation
CLINICAL_TRIALS study record update · 2023-07-11
Randomized Phase Ⅱ Study of Second-line Treatment Comparing Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, 5-fluorouracil and Leucovorin With Sorafenib in Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization
CLINICAL_TRIALS study record update · 2023-07-11
Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2023-07-10
Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators to Follow-up the Activities of Different Cancer Pathologies
CLINICAL_TRIALS study record update · 2023-07-10
An Open-label Phase 2 Trial of Dual TORC1/TORC2 Inhibitor ATG-008 in HBV+ Advanced Hepatocellular Carcinoma (HCC) Subjects Who Have Received at Least One Prior Line of Systemic Therapy (TORCH)
CLINICAL_TRIALS study record update · 2023-07-10
An Open-Label Preoperative Pilot Study Evaluating Nivolumab (Anti-PD-1 Antibody) Alone Versus Nivolumab Plus Ipilimumab (Anti-CTLA-4 Antibody) in Patients With Resectable (HCC)
CLINICAL_TRIALS study record update · 2023-07-07
Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens for Genetic and Histologic Research